Collecting data on patients with diffuse lung diseases
Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases
This study is collecting information from patients with lung diseases to better understand their causes, how common they are, and how they respond to treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 21 Years to 90 Years |
| Sex | All |
| Sponsor | Singapore General Hospital Academic / other |
| Locations | 1 site (Singapore) |
| Trial ID | NCT01600378 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive database of patients diagnosed with diffuse parenchymal lung diseases, including conditions like interstitial lung disease and idiopathic pulmonary fibrosis. By evaluating various disease causes, incidence and prevalence rates, clinical and radiological presentations, and treatment responses, the study seeks to enhance understanding of these conditions. The data collected will help in assessing disease progression and final outcomes for patients in Singapore.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 21 and older who have been diagnosed with suspected diffuse parenchymal lung disease.
Not a fit: Patients who do not have suspected diffuse parenchymal lung disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that improve diagnosis and treatment strategies for patients with diffuse parenchymal lung diseases.
How similar studies have performed: While this study focuses on data collection, similar observational studies have previously contributed to advancements in understanding lung diseases, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients 21 years old and older diagnosed with suspected diffuse parenchymal lung disease (multi-lobar pulmonary infiltrates) Exclusion Criteria: * None
Where this trial is running
Singapore
- Singapore General Hospital — Singapore, Singapore (Recruiting)
Study contacts
- Principal investigator: Su Ying Low, BMBCh — Singapore General Hospital
- Study coordinator: Su Ying Low, BMBCh
- Email: low.su.ying@singhealth.com.sg
- Phone: +65 63214700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.